Rice Louis B
Medical Service, Louis Stokes Cleveland Veterans Affairs Medical Center, and Case Western Reserve University, Cleveland, Ohio 44106, USA.
Clin Infect Dis. 2008 Feb 15;46(4):491-6. doi: 10.1086/526535.
Antimicrobial resistance is frequently associated with clinical use of antibiotics. This close association suggests that efforts to manage our use of these potent agents can have an impact on the prevalence of resistance. Unfortunately, one size does not fit all when considering the response of bacterial pathogens to antimicrobial exposure. Measures that may prevent resistance in some species (such as using multiple antibiotics to treat tuberculosis) may exacerbate the problem of resistance in others (such as Pseudomonas aeruginosa or Acinetobacter baumannii). The simplest approach is to use fewer antibiotics and thereby apply less selective pressure to the prevalent flora. Among available strategies to reduce use, reductions in length of antimicrobial regimens are the safest and are likely to be the most palatable to practicing clinicians. Studies are urgently needed to define minimal lengths of therapy to ensure that efforts at reduced use are safe and effective.
抗菌药物耐药性常常与抗生素的临床使用相关。这种紧密关联表明,管理这些强效药物使用的努力可能会对耐药性的流行产生影响。不幸的是,在考虑细菌病原体对抗菌药物暴露的反应时,并非一概而论。在某些物种中可能预防耐药性的措施(如使用多种抗生素治疗结核病)可能会加剧其他物种(如铜绿假单胞菌或鲍曼不动杆菌)的耐药性问题。最简单的方法是减少抗生素的使用,从而对常见菌群施加较小的选择压力。在现有的减少使用的策略中,缩短抗菌治疗疗程是最安全的,并且可能是执业临床医生最容易接受的。迫切需要开展研究来确定最短治疗疗程,以确保减少使用的努力是安全有效的。